HRX215
Product Specifications
CAS Number
2369583-33-3
Synonyms
Darizmetinib
SKU
C01965-5mg
Target
P38 MAPK
Applications
MAPK
Additionnal Information
HRX215 (Darizmetinib) is a first-in-class, highly potent, selective, and orally active inhibitor of MKK4 with an IC50 of 0.02 μM. It enhances liver regeneration, prevents liver failure following extensive hepatectomy in pigs, and has potential to prevent liver failure after major oncological liver resections or transplantation of small liver grafts in humans.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
033202-HRP 200 µL
CASP12, ID (CASP12, Inactive caspase-12) (Azide free) (HRP) discontinued
Ask
View Details 
168378 100 µL
MTBP (MDM 2 BP, MDM2 (mouse double minute 2) binding protein 104kD, MDM2 (mouse double minute 2) binding protein, MDM2 Binding Protein, MDM2 BP)
Ask
View Details MBS6339567-02 5x 0.1 mL
Rab17, ID (Rab17, Ras-related protein Rab-17) (MaxLight 750)
Ask
View Details